Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Cardiotoxicity
Interventions: DRUG: Bisoprolol|DRUG: Ramipril|DRUG: Placebo
Sponsor: Azienda Ospedaliero-Universitaria Careggi
Collaborators: University of Florence